Bluejay Diagnostics, Inc. BJDX
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -7.95% | 4.83% | 11.27% | 20.24% | 28.39% |
| Total Depreciation and Amortization | -0.55% | -14.39% | -14.26% | -26.85% | -58.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 686.21% | -86.12% | -87.04% | -88.36% | -97.84% |
| Change in Net Operating Assets | 484.51% | 650.32% | 191.83% | 155.30% | -150.90% |
| Cash from Operations | 13.76% | 3.69% | 22.59% | 33.86% | 15.68% |
| Capital Expenditure | -25,707.69% | 28.97% | 43.36% | 99.72% | 99.72% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -25,423.08% | 30.34% | 43.36% | 99.72% | 99.72% |
| Total Debt Issued | -- | -- | -- | -100.00% | -100.00% |
| Total Debt Repaid | 97.23% | 99.80% | 99.80% | 99.80% | 91.85% |
| Issuance of Common Stock | 241.16% | -1.14% | -30.85% | -68.13% | -71.84% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -272.30% | -10.51% | 32.09% | 74.83% | 79.44% |
| Cash from Financing | 252.57% | -2.92% | -30.63% | -66.95% | -72.01% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 242.61% | 24.95% | -58.78% | -493.84% | -222.22% |